Similar Search Results

Selection dynamics, asymptotic stability, and adaptive behavior

Van Huyck, John Bronston - In: Journal of political economy 102 (1994) 5, pp. 975-1005

Persistent link: https://www.econbiz.de/10001175727

How excluding some benefits from value assessment of new drugs impacts innovation

Cook, Joseph P.; Golec, Joseph - In: Health economics 26 (2017) 12, pp. 1813-1825

Persistent link: https://www.econbiz.de/10011817950

The relationship between price regulation and pharmaceutical profit margins

Vernon, John A. - In: Applied economics letters 10 (2003) 8, pp. 467-470

Persistent link: https://www.econbiz.de/10001770569

The value of time, with and without a smartphone

Randriamaro, Mary Tiana; Cook, Joseph - In: Journal of economic behavior & organization : JEBO 200 (2022), pp. 138-146

Persistent link: https://www.econbiz.de/10013387307

Economic Evaluation and Comparative-Effectiveness Thresholds : Signals to Firms and Implications for R&D Investment and Innovation

Vernon, John A. - 2009

In this article we describe how reimbursement cost-effectiveness thresholds, per unit of health benefit, whether set explicitly or observed implicitly via historical reimbursement decisions, serve as a signal to firms about the commercial viability of their R&D projects (including candidate...

Persistent link: https://www.econbiz.de/10013160444

Drug development costs when financial risk is measured using the Fama-French three-factor model

Vernon, John A.; Golec, Joseph; DiMasi, Joseph A. - In: Health economics 19 (2010) 8, pp. 1002-1005

Persistent link: https://www.econbiz.de/10008651842